Xinjian Wan

1.6k total citations
84 papers, 1.1k citations indexed

About

Xinjian Wan is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xinjian Wan has authored 84 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 37 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Xinjian Wan's work include Gallbladder and Bile Duct Disorders (22 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers) and Pancreatic and Hepatic Oncology Research (12 papers). Xinjian Wan is often cited by papers focused on Gallbladder and Bile Duct Disorders (22 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers) and Pancreatic and Hepatic Oncology Research (12 papers). Xinjian Wan collaborates with scholars based in China, United States and Saudi Arabia. Xinjian Wan's co-authors include Zhixia Dong, Qian Zhuang, Xin Ye, Lungen Lu, Shan Wu, Shuang Shen, Xiaobo Cai, Mingyi Xu, Dan Huang and Hui Zhou and has published in prestigious journals such as Nature Communications, PLoS ONE and Cell Metabolism.

In The Last Decade

Xinjian Wan

73 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinjian Wan China 18 389 343 258 246 180 84 1.1k
Kazuhiro Watanabe Japan 18 383 1.0× 224 0.7× 207 0.8× 377 1.5× 213 1.2× 81 1.1k
Fangfang Liu China 20 212 0.5× 359 1.0× 205 0.8× 617 2.5× 174 1.0× 63 1.4k
K Orita Japan 17 344 0.9× 319 0.9× 183 0.7× 354 1.4× 128 0.7× 122 1.2k
Shilong Zhang China 18 125 0.3× 588 1.7× 143 0.6× 255 1.0× 117 0.7× 95 1.2k
Luigi Moro Italy 20 259 0.7× 448 1.3× 63 0.2× 238 1.0× 435 2.4× 59 1.6k
Weihui Zhang China 17 323 0.8× 387 1.1× 99 0.4× 156 0.6× 112 0.6× 76 953
Jianfang Li China 16 301 0.8× 278 0.8× 180 0.7× 171 0.7× 55 0.3× 31 996
A.-H. Kwon Japan 17 401 1.0× 94 0.3× 264 1.0× 295 1.2× 287 1.6× 43 1.0k

Countries citing papers authored by Xinjian Wan

Since Specialization
Citations

This map shows the geographic impact of Xinjian Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjian Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjian Wan more than expected).

Fields of papers citing papers by Xinjian Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinjian Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjian Wan. The network helps show where Xinjian Wan may publish in the future.

Co-authorship network of co-authors of Xinjian Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xinjian Wan. A scholar is included among the top collaborators of Xinjian Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinjian Wan. Xinjian Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Anlin, Xinjian Wan, Binbin Sun, et al.. (2025). Chitosan and ibuprofen grafted electrospun polylactic acid/gelatin membrane mitigates inflammatory response. Biomedical Materials. 20(2). 25024–25024.
3.
Lu, Jie, Yuejun Liu, Ni Zhang, et al.. (2024). Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10. Molecular Metabolism. 89. 102030–102030. 7 indexed citations
4.
Huang, Dan, Shuang Shen, Qian Zhuang, et al.. (2024). Ganoderma lucidum polysaccharide ameliorates cholesterol gallstone formation by modulating cholesterol and bile acid metabolism in an FXR-dependent manner. Chinese Medicine. 19(1). 16–16. 11 indexed citations
5.
Shi, Yan, Caiyun Ma, Xin Ye, et al.. (2024). ETS translocation variant 5 (ETV5) promotes CD4+ T cell–mediated intestinal inflammation and fibrosis in inflammatory bowel diseases. Mucosal Immunology. 17(4). 584–598. 5 indexed citations
6.
Zhuang, Qian, Shan Wu, Shuang Shen, et al.. (2024). Association between sleep and gallstone disease in United States adults: A cross-sectional study. BMC Public Health. 24(1). 3291–3291. 2 indexed citations
7.
Dong, Zhixia, Xiongzhu Bu, Congying Chen, et al.. (2024). A deep learning model based on magnifying endoscopy with narrow-band imaging to evaluate intestinal metaplasia grading and OLGIM staging: A multicenter study. Digestive and Liver Disease. 56(9). 1565–1571. 1 indexed citations
8.
9.
Liu, Tianyuan, et al.. (2023). Enhancing gastrointestinal submucosal tumor recognition in endoscopic ultrasonography: A novel multi-attribute guided contextual attention network. Expert Systems with Applications. 242. 122725–122725. 4 indexed citations
10.
Shen, Shuang, Dan Huang, Xin Ye, et al.. (2023). Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota. European Journal of Pharmacology. 955. 175891–175891. 12 indexed citations
11.
Ye, Xin, Dan Huang, Zhixia Dong, et al.. (2022). FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains. Microbiology Spectrum. 10(5). e0051822–e0051822. 43 indexed citations
13.
Li, Wenhua, et al.. (2022). m5C and m6A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR‐582‐3p‐YAP1 axis. Liver International. 42(5). 1144–1157. 35 indexed citations
14.
Ye, Xin, Shuang Shen, Qian Zhuang, et al.. (2021). Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism. European Journal of Pharmacology. 908. 174341–174341. 35 indexed citations
16.
Zhang, Weixing, Fariha Kanwal, Muhammad Fayyaz ur Rehman, & Xinjian Wan. (2021). Efficacy of Biodegradable Polydioxanone and Polylactic Acid Braided Biodegradable Biliary Stents for the Management of Benign Biliary Strictures. The Turkish Journal of Gastroenterology. 32(8). 651–660. 8 indexed citations
17.
Xiao, Jingbo, et al.. (2020). Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma. BMC Gastroenterology. 20(1). 322–322. 1 indexed citations
18.
Chen, Sumin, Qiuyan Zhao, Lili Guo, et al.. (2020). Comparative assessment of the biocompatibility and degradation behavior of Zn-3Cu and JDBM alloys used for biliary surgery.. PubMed. 12(1). 19–31. 5 indexed citations
19.
Zhang, Wenlong, Jingbo Xiao, Qing Cao, et al.. (2018). An easy-to-fabricate clearable CuS-superstructure-based multifunctional theranostic platform for efficient imaging guided chemo-photothermal therapy. Nanoscale. 10(24). 11430–11440. 24 indexed citations
20.
Cai, Xiaobo, Mingyi Xu, Ying Qu, et al.. (2015). Peritumoral ductular reaction is related to nuclear translocation of β-catenin in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 76. 11–16. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026